As only ten primary melanoma samples from patients who succumbed to disease were available, we performed a correlation analysis on SOX5 expression and survival time resulting in a strongly negative (r = -0.65) correlation, whereas in metastatic melanoma samples only a weak correlation could be observed (r = -0.12; not shown). Here, SOX5 is linked to melanoma.